openPR Logo
Press release

Rabeprazole Sodium Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029

01-13-2023 05:00 PM CET | Health & Medicine

Press release from: Orion Market Research

Rabeprazole Sodium Market Trends, Research Report, Growth,

During the forecast period, the global rabeprazole sodium market is expected to rise at a considerable CAGR. The market growth is being driven by the rising prevalence rate of gastroesophageal reflux diseases (GERD), duodenal ulcers, and other gut-related infections and diseases globally, which has surged the demand for better treatment options. As per the World Gastroenterology Organization, the prevalence rate of GERD is growing rapidly across the world. It was valued at approximately 2.5%-6.6% in South East Asia and almost 13.8%-25.8% in North America. Moreover, in 2019, the global prevalence of duodenal or peptic ulcer prevalence was approximately 8.09 million representing a 25.82% increase from 1990. The increase in the number of cigarette smokers, alcohol/tobacco consumers, and a significant increase in food habits are the major cause of these diseases. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives but also extends to the healthcare system and economy.

To learn more about this report request a sample copy @

The prominent players in the market are focusing on acquisition and partnership collaboration with other market players to broaden their product offering in order to fulfill the growing market demand. For instance, in December 2021, Pfizer Inc. acquired Arena Pharmaceuticals, Inc along with its all the outstanding shares for $100 per share in an all-cash transaction for a total equity value of approximately $6.7 billion, via a definitive agreement. Through this acquisition, the company acquired Arena's portfolio which includes diverse and promising development-stage therapeutic candidates in gastroenterology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a range of immuno-inflammatory diseases including gastrointestinal and dermatological diseases.

Market Coverage

• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
Segment Covered-
• By Type
• By Application
Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
Competitive Landscape- including ASN Co., Intas Pharmaceutical Ltd., Pfizer Inc., Sandoz Inc. (Novartis International AG)), Teva Pharmaceutical Industries Ltd., and others.?

Key questions addressed by the report

• What is the market growth rate?
• That segment and region dominate the market in the base year?
• That segment and region will project the fastest growth in the market?
• How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Rabeprazole Sodium Market Report Segment

By Type

• Rabeprazole Sodium Monohydrate
• Rabeprazole Sodium Crystalline

By Application

• Gastroesophageal Reflux Disease Treatment
• Duodenal Ulcer Treatment
• Others

A full report of Rabeprazole Sodium Market is available at:

Rabeprazole Sodium Market- Segment by Region

North America

• United States
• Canada


• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe


• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• including ASN Co.
• Intas Pharmaceutical Ltd.
• Pfizer Inc.
• Sandoz Inc. (Novartis International AG))
• Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

Media Contact:

Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rabeprazole Sodium Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029 here

News-ID: 2883173 • Views: 215

More Releases from Orion Market Research

North American 3D Cell Culture Market Trends, Segmentation, Growth, Analysis and …
The North American 3D cell culture market is expected to witness a significant growth with the CAGR of 13.3% during the forecast period. The North American market for 3D cell culture is a significant market and is analyzed on the basis of the country such as the US and Canada. North American 3D Cell Culture Market reports provides us with a complete outlook on thorough assessment of thorough data about
European Diagnostic Biomarker Market Share, Trends, Future Outlook, Analysis and …
The European diagnostic biomarker market is estimated to grow significantly at a CAGR of more than 11% during the forecast period. Factors that are contributing significantly in the market growth include the presence of a well-developed healthcare sector and considerably high healthcare expenditure and infrastructure in its economies such as Germany, UK, France and many more. European Diagnostic Biomarker Market reports provides us with a complete outlook on thorough assessment
European Biological Sample Handling Market Size, Share, Growth, Analysis and For …
The European biological sample handling market is forecast to grow at a CAGR of around 8.4% during the forecast period. Europe is expected to share significantly in the global biological sample handling market owing to the well-developed healthcare sector, and significant research in the field of geniomics and protecomics in its economies such as UK, Germany, Italy, Spain and many more. European Biological Sample Handling Market reports provides us with
Asia-Pacific Biological Sample Handling Market Size, Share, Growth, Analysis and …
Asia-Pacific Biological Sample Handling market is expected to grow at CAGR of around 9.3% during the forecast period. Asia-Pacific is estimated to be a potential market for biological sample handling due to the increasing R&D and investments by government organizations in life science research. Asia-Pacific Biological Sample Handling Market reports provides us with a complete outlook on thorough assessment of thorough data about vital feature of the global industry related

All 5 Releases

More Releases for Rabeprazole

Rabeprazole Sodium Market to Surge at a Robust Pace in Terms of Revenue Over 203 …
Rabeprazole Sodium Market - Overview The global rabeprazole sodium market is expected to expand at a healthy rate from 2021 to 2031 (forecast period). The rise in awareness of the advantages of rabeprazole sodium and the spike in demand for proton pump inhibitors is projected to boost the global rabeprazole sodium market during the forecast period. Moreover, the surge in gastroesophageal reflux disease (GERD) and ulcer cases is anticipated to contribute
2022 Rabeprazole Market Report- Trends, Growth Demand, Opportunities & Forecast …
The research study offers a detailed breakdown of the Rabeprazole Market, including market volume, size, and value across all industries. It also provides a comprehensive overview of the Rabeprazole Market supported by pie charts, graphs, and figures to make it easy to understand the market. Furthermore, the Rabeprazole Market study develops regional trends, preferred marketing channels, long-term stability, and environmental analysis. Rabeprazole Market also contains product capacities, price, profit statements,
Latest Rabeprazole Market Report- by Key Segments, Growth Size, Emerging Trends …
In today's competitive world, you need to think one step ahead to pursue your competitors; this Rabeprazole Market research report provides previews and top-notch information about key players, major collaborations, mergers & acquisitions along with trending innovation and business policies to present a better understanding to drive the business in the correct direction. Get FREE PDF Sample of the Report @ Rabeprazole market is segmented by Type and by Application. Players,
2022 Rabeprazole Market Report- Size Growth Rate by Application | Peptic Ulcer D …
The global Rabeprazole Market research report is beneficial to build business strategies or modify business expansion plans by utilized substantial growth offering developed and emerging markets. Moreover, Rabeprazole Market provides various analyses to strive in the market; one of the analyses called Porter's five force analysis used in Rabeprazole Market report unveils the intensity of the competitive rivalry and bargaining powers of buyers and suppliers. Get FREE PDF Sample of the
Rising Demand for Rabeprazole Sodium Market Key Players, Growth Analysis during …
The global rabeprazole sodium market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Rabeprazole is used for the treatment of duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It is a condition where the stomach produces too much acid. Rabeprazole sodium can also be used together with antibiotics such as amoxicillin, clarithromycin for the treatment of ulcers that are caused by the H. pylori
Rabeprazole Sodium Market Technology, Recent Trends, Future Growth Analysis Fore …
The pH level in the human digestive system must be kept within a certain range. Acidity levels rise as a result of a variety of causes, including spicy food consumption, pharmaceutical side effects, and so on. Rabeprazole sodium is a combination of rabeprazole and other medications. It helps to lower stomach acid and is used to treat conditions like gastric reflux disease, duodenal ulcers, and bacterial infections in the stomach